Search
for
Sort by
Research 961–990 of 1000+
- Immunopathogenesis and Experimental Models of Alopecia Areata: From Mechanistic Insights to Translational Platforms
- POLY-HERBAL HAIR REMOVAL CREAM: AN EFFECTIVE AND NATURAL APPROACH TO HAIR REMOVAL
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Ottawa, Ontario, Canada, February 13–16, 2013
- Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Hairless triggers reactivation of hair growth by promoting Wnt signaling
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia
- Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- The Many Faces of Calcineurin Inhibitor Toxicity—What the FK?
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Female pattern hair loss
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Adverse effects of common medications on male fertility
- Safety of dermatologic medications in pregnancy and lactation
- Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Management of congenital ichthyoses: European guidelines of care, part two
- Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
- Hormonal treatment of acne vulgaris: an update
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Biomaterial-based mechanical regulation facilitates scarless wound healing with functional skin appendage regeneration
- Treatment options for alopecia: an update, looking to the future
- Glucocorticoid Receptor Mutants Demonstrate Increased Motility Inside the Nucleus of Living Cells: Time of Fluorescence Recovery After Photobleaching (FRAP) Is an Integrated Measure of Receptor Function